AzTrials
AzTrials

Rupture of Anterior Cruciate LigamentNCT02834962

Study of Single And Double Bundle Anterior Cruciate Ligament (ACL) Graft Cross-sectional Dimensions

A study testing single bundle ACL reconstruction and double bundle ACL reconstruction in people with Rupture of Anterior Cruciate Ligament, run by Peking University Third Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To study the difference between single and double bundle ACL graft cross-sectional dimensions compared with native ACL using postoperative 3-D MRI. Read more about this study

Who is it for?
Ages 10 to 50 years
Conditions the study is for
Rupture of Anterior Cruciate Ligament
What is being tested?
single bundle ACL reconstruction and double bundle ACL reconstruction
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
Jul 2016to Aug 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 50 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • ACL rupture patients aged between 10 to 50 years

Who cannot join

  • combined severe injuries to the operated knee (additional ligament rupture, major meniscus loss, patella instability, cartilage damage >2°, pathologic leg axis deviation)
  • any injury or surgery to the contralateral knee
  • any inflammatory or systemic disease, neuromuscular disease in the lower limbs,any recent knee infection

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Study of Single And Double Bundle ACL Graft Cross-sectional Dimensions Compared With Native ACL

To study the difference between single and double bundle ACL graft cross-sectional dimensions compared with native ACL using postoperative 3-D MRI.

Read the detailed description

The investigators divide 100 patients with ACL rupture into 2 groups. Group A undergo single bundle anterior cruciate ligament reconstruction (ACLR). Group B undergo double bundle ACL reconstruction. At 3-6 weeks post operation, all the patients undergo 3-D MRI examination of both knees. The investigators reconstruct 3-D models of reconstructed ACL and native ACL, and compare the difference between single and double bundle graft.

Being tested
single bundle ACL reconstruction, double bundle ACL reconstruction
Keywords
Anterior Cruciate Ligament Reconstruction
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • single bundle ACL reconstructionProcedure or surgery

    anterior cruciate ligament reconstruction using single bundle technique

  • double bundle ACL reconstructionProcedure or surgery

    anterior cruciate ligament reconstruction using double bundle technique

Study groups in NCT02834962
Study groupRoleWhat they receive
single bundle ACLRExperimentalpatients undergo single bundle ACL reconstruction
Receives: Procedure: single bundle ACL reconstruction
double bundle ACLRActive comparatorpatients undergo double bundle ACL reconstruction
Receives: Procedure: double bundle ACL reconstruction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cross-sectional area of the reconstructed ACL

    Measured: 3-6 weeks

  2. long to short axis ratio of the cross-sectional area of the reconstructed ACL

    Measured: 3-6 weeks

  3. long axis of the cross-sectional area of the reconstructed ACL

    Measured: 3-6 weeks

  4. short axis of the cross-sectional area of the reconstructed ACL

    Measured: 3-6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2016 (estimated)
  2. Study startJul 2016
  3. Primary completionJul 2017 (estimated)
  4. Study completionAug 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02834962
Sponsor's protocol ID
ACLMRI-1
Status last verified
Jul 2016
First submitted
13 Jul 2016
Last updated
18 Jul 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing single bundle ACL reconstruction and double bundle ACL reconstruction in people with Rupture of Anterior Cruciate Ligament, run by Peking University Third Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yu Jia-Kuo, MD (86-10-82267392, yujiakuo@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cross-sectional area of the reconstructed ACL (time frame: 3-6 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in